Why everyone's talking about biosimilars
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to wishlist failed.
Please try again later
Remove from wishlist failed.
Please try again later
Adding to library failed
Please try again
Follow podcast failed
Unfollow podcast failed
Why everyone's talking about biosimilars
-
Narrated by:
-
By:
About this listen
Joshua Fredell, SVP, Pharmacy Services, shares insights on this biologic drug and why it matters.
• Our history of innovation at CVS Caremark demonstrates that we are uniquely positioned to positively impact the market.
• Members feel supported when their prescription plan prioritizes affordability, and their biosimilars are backed by regulatory approval for safety and efficacy, Joshua notes.
• "If we remain focused on driving to lower-cost products and using our technology to make that even easier for everyone involved, we will be able to maximize the savings potential that biosimilars provide," Joshua says.
No reviews yet